238 related articles for article (PubMed ID: 22405131)
1. Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.
Liu M; Wang L; Bongartz T; Hawse JR; Markovic SN; Schaid DJ; Mushiroda T; Kubo M; Nakamura Y; Kamatani N; Goss PE; Ingle JN; Weinshilboum RM
Breast Cancer Res; 2012 Mar; 14(2):R41. PubMed ID: 22405131
[TBL] [Abstract][Full Text] [Related]
2. Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.
Ho MF; Bongartz T; Liu M; Kalari KR; Goss PE; Shepherd LE; Goetz MP; Kubo M; Ingle JN; Wang L; Weinshilboum RM
Mol Endocrinol; 2016 Mar; 30(3):382-98. PubMed ID: 26866883
[TBL] [Abstract][Full Text] [Related]
3.
Ho MF; Ingle JN; Bongartz T; Kalari KR; Goss PE; Shepherd LE; Mushiroda T; Kubo M; Wang L; Weinshilboum RM
Mol Pharmacol; 2017 Aug; 92(2):175-184. PubMed ID: 28615284
[TBL] [Abstract][Full Text] [Related]
4.
Ho MF; Lummertz da Rocha E; Zhang C; Ingle JN; Goss PE; Shepherd LE; Kubo M; Wang L; Li H; Weinshilboum RM
J Pharmacol Exp Ther; 2018 Jun; 365(3):700-710. PubMed ID: 29592948
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
Ingle JN; Schaid DJ; Goss PE; Liu M; Mushiroda T; Chapman JA; Kubo M; Jenkins GD; Batzler A; Shepherd L; Pater J; Wang L; Ellis MJ; Stearns V; Rohrer DC; Goetz MP; Pritchard KI; Flockhart DA; Nakamura Y; Weinshilboum RM
J Clin Oncol; 2010 Nov; 28(31):4674-82. PubMed ID: 20876420
[TBL] [Abstract][Full Text] [Related]
6. Immune Mediator Pharmacogenomics:
Ho MF; Weinshilboum RM
J Nat Sci; 2017 Aug; 3(8):. PubMed ID: 28868359
[TBL] [Abstract][Full Text] [Related]
7. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
Liu M; Ingle JN; Fridley BL; Buzdar AU; Robson ME; Kubo M; Wang L; Batzler A; Jenkins GD; Pietrzak TL; Carlson EE; Goetz MP; Northfelt DW; Perez EA; Williard CV; Schaid DJ; Nakamura Y; Weinshilboum RM
Mol Endocrinol; 2013 Apr; 27(4):657-70. PubMed ID: 23518928
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.
Liu M; Goss PE; Ingle JN; Kubo M; Furukawa Y; Batzler A; Jenkins GD; Carlson EE; Nakamura Y; Schaid DJ; Chapman JA; Shepherd LE; Ellis MJ; Khosla S; Wang L; Weinshilboum RM
Mol Endocrinol; 2014 Oct; 28(10):1740-51. PubMed ID: 25148458
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
Bodine PV; Harris HA; Komm BS
Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.
Ingle JN; Xie F; Ellis MJ; Goss PE; Shepherd LE; Chapman JW; Chen BE; Kubo M; Furukawa Y; Momozawa Y; Stearns V; Pritchard KI; Barman P; Carlson EE; Goetz MP; Weinshilboum RM; Kalari KR; Wang L
Cancer Res; 2016 Dec; 76(23):7012-7023. PubMed ID: 27758888
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
Umamaheswaran G; Kadambari D; Muthuvel SK; Kumar NAN; Dubashi B; Aibor Dkhar S; Adithan C
PLoS One; 2021; 16(3):e0247989. PubMed ID: 33760860
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.
Cairns J; Ingle JN; Dudenkov TM; Kalari KR; Carlson EE; Na J; Buzdar AU; Robson ME; Ellis MJ; Goss PE; Shepherd LE; Goodnature B; Goetz MP; Weinshilboum RM; Li H; Bari MG; Wang L
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32701512
[TBL] [Abstract][Full Text] [Related]
13. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
Lintermans A; Van Asten K; Jongen L; Van Brussel T; Laenen A; Verhaeghe J; Vanderschueren D; Lambrechts D; Neven P
Eur J Cancer; 2016 Mar; 56():31-36. PubMed ID: 26798969
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
[TBL] [Abstract][Full Text] [Related]
15. Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alpha.
Suzuki T; Shimizu T; Yu HP; Hsieh YC; Choudhry MA; Chaudry IH
Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2103-11. PubMed ID: 17287365
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.
Masri S; Phung S; Wang X; Wu X; Yuan YC; Wagman L; Chen S
Cancer Res; 2008 Jun; 68(12):4910-8. PubMed ID: 18559539
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of aromatase inhibitors.
Hadfield KD; Newman WG
Pharmacogenomics; 2012 Apr; 13(6):699-707. PubMed ID: 22515612
[TBL] [Abstract][Full Text] [Related]
18. Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.
Pratt MA; Bishop TE; White D; Yasvinski G; Ménard M; Niu MY; Clarke R
Mol Cell Biol; 2003 Oct; 23(19):6887-900. PubMed ID: 12972607
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.
Kurebayashi S; Miyashita Y; Hirose T; Kasayama S; Akira S; Kishimoto T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):11-7. PubMed ID: 9182853
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
